Copyright
©The Author(s) 2017.
World J Cardiol. Sep 26, 2017; 9(9): 723-730
Published online Sep 26, 2017. doi: 10.4330/wjc.v9.i9.723
Published online Sep 26, 2017. doi: 10.4330/wjc.v9.i9.723
Table 2 Natriuretic peptide/cardiac myonecrosis marker ratio in takotsubo cardiomyopathy and acute coronary syndrome
Ref. | Biomarker and time of collection | Takotsubo cardiomyopathy | Acute coronary syndrome | ||
Frölich et al[36] | NT-proBNP (peak) | Cutoff NT-proBNP/TnT to differentiate TC and NSTEMI | Cutoff NT-proBNP/TnT to differentiate TC and STEMI | ||
TnT (peak) | 5000 | 2889 | |||
Lahoti et al[37] | NT-proBNP (mean) | NT-proBNP/TnT | NT-proBNP/TnT (STEMI) | ||
TnT (peak) | 5154 ± 1891.2 | 183 ± 128.9 | |||
Randhawa et al[38] | First simultaneous BNP and TnT | BNP/TnT | BNP/CKMB | BNP/TnT (AMI) | BNP/CKMB (AMI) |
1292 (443.4-2657.9) | 28.44 (13.7-94.8) | 226.9 (69.9-426.3) | 3.63 (1.1-10.0) | ||
Doyen et al[39] | BNP (admission) | BNP/TnI | BNP/TnI (NSTEMI) | BNP/TnI (STEMI) | |
TnI (peak) | 642 (331.8-1226.5) | 184.5 (50.5-372.3) | 7.5 (2.0-29.6) |
- Citation: Gopalakrishnan P, Zaidi R, Sardar MR. Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis. World J Cardiol 2017; 9(9): 723-730
- URL: https://www.wjgnet.com/1949-8462/full/v9/i9/723.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i9.723